ICON buys Pennsylvania PR firm for $120m
Leopardstown-based clinical trials firm ICON said it is buying US-based MediMedia Pharma Solutions for $120m.
Pennsylvania-based MediMedia Pharma Solutions is a division of MediMedia USA and is owned by Vestar Capital Partners.
ICON said the deal will strengthen its expertise in scientific communications and market access.
"The need to demonstrate and communicate the value of new medicines is an important global healthcare trend," said ICON chief executive Ciaran Murray.
"Through ICON's market leading commercialisation and outcomes group we are supporting our customers to maximise the value of their new drugs.
"Our acquisition of MediMedia Pharma Solutions deepens the expertise of this group and brings us outstanding scientific and medical communications capabilities," he added.